334 related articles for article (PubMed ID: 11238587)
1. Lyn is essential for fcgamma receptor III-mediated systemic anaphylaxis but not for the Arthus reaction.
Yuasa T; Ono M; Watanabe T; Takai T
J Exp Med; 2001 Mar; 193(5):563-72. PubMed ID: 11238587
[TBL] [Abstract][Full Text] [Related]
2. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.
Ujike A; Ishikawa Y; Ono M; Yuasa T; Yoshino T; Fukumoto M; Ravetch JV; Takai T
J Exp Med; 1999 May; 189(10):1573-9. PubMed ID: 10330436
[TBL] [Abstract][Full Text] [Related]
3. Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis.
Falanga YT; Chaimowitz NS; Charles N; Finkelman FD; Pullen NA; Barbour S; Dholaria K; Faber T; Kolawole M; Huang B; Odom S; Rivera J; Carlyon J; Conrad DH; Spiegel S; Oskeritzian CA; Ryan JJ
J Immunol; 2012 May; 188(9):4360-8. PubMed ID: 22450804
[TBL] [Abstract][Full Text] [Related]
4. IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells.
Gast M; Preisinger C; Nimmerjahn F; Huber M
Front Immunol; 2018; 9():1937. PubMed ID: 30210494
[TBL] [Abstract][Full Text] [Related]
5. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.
Dombrowicz D; Flamand V; Miyajima I; Ravetch JV; Galli SJ; Kinet JP
J Clin Invest; 1997 Mar; 99(5):915-25. PubMed ID: 9062349
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of genes linked to FcepsilonRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells.
Hernandez-Hansen V; Bard JD; Tarleton CA; Wilder JA; Lowell CA; Wilson BS; Oliver JM
J Immunol; 2005 Dec; 175(12):7880-8. PubMed ID: 16339523
[TBL] [Abstract][Full Text] [Related]
7. Scrodentoid A Inhibits Mast Cell-Mediated Allergic Response by Blocking the Lyn-FcεRIβ Interaction.
Qian F; Zhang L; Lu S; Mao G; Guo F; Liu P; Xu J; Li Y
Front Immunol; 2019; 10():1103. PubMed ID: 31156646
[No Abstract] [Full Text] [Related]
8. Effect of kaempferol on IgE-mediated anaphylaxis in C57BL/6 mice and LAD2 cells.
Cao J; Li C; Ma P; Ding Y; Gao J; Jia Q; Zhu J; Zhang T
Phytomedicine; 2020 Dec; 79():153346. PubMed ID: 33002828
[TBL] [Abstract][Full Text] [Related]
9. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.
Miyajima I; Dombrowicz D; Martin TR; Ravetch JV; Kinet JP; Galli SJ
J Clin Invest; 1997 Mar; 99(5):901-14. PubMed ID: 9062348
[TBL] [Abstract][Full Text] [Related]
10. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
11. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
12. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
14. Suppression of IgE-mediated mast cell activation and mouse anaphylaxis via inhibition of Syk activation by 8-formyl-7-hydroxy-4-methylcoumarin, 4μ8C.
Nam ST; Park YH; Kim HW; Kim HS; Lee D; Lee MB; Kim YM; Choi WS
Toxicol Appl Pharmacol; 2017 Oct; 332():25-31. PubMed ID: 28736076
[TBL] [Abstract][Full Text] [Related]
15. Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival.
Kitaura J; Xiao W; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Kawakami T
J Immunol; 2004 Oct; 173(7):4317-23. PubMed ID: 15383560
[TBL] [Abstract][Full Text] [Related]
16. Anti-FcγRIIB mAb suppresses murine IgG-dependent anaphylaxis by Fc domain targeting of FcγRIII.
Clay CD; Strait RT; Mahler A; Khodoun MV; Finkelman FD
J Allergy Clin Immunol; 2018 Apr; 141(4):1373-1381.e5. PubMed ID: 28624610
[TBL] [Abstract][Full Text] [Related]
17. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
[TBL] [Abstract][Full Text] [Related]
18. Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.
Nunes de Miranda SM; Wilhelm T; Huber M; Zorn CN
Cell Commun Signal; 2016 May; 14(1):12. PubMed ID: 27206658
[TBL] [Abstract][Full Text] [Related]
19. WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo.
Park YH; Kim DK; Kim HS; Lee D; Lee MB; Min KY; Jo MG; Lee JE; Kim YM; Choi WS
Toxicol Appl Pharmacol; 2019 Nov; 383():114763. PubMed ID: 31526816
[TBL] [Abstract][Full Text] [Related]
20. Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells.
Burton OT; Epp A; Fanny ME; Miller SJ; Stranks AJ; Teague JE; Clark RA; van de Rijn M; Oettgen HC
Front Immunol; 2018; 9():1244. PubMed ID: 29928276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
